Coronary Artery Disease Progression Clinical Trial
Official title:
Proteomics and Genomics Combined With CT to Predict CVD
This study evaluates plaque progression and characteristics in patients with coronary atherosclerosis.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05462262 -
Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population
|
N/A | |
Not yet recruiting |
NCT06040073 -
Natural History of Coronary Atherosclerosis
|
||
Active, not recruiting |
NCT03349385 -
Registry of Secondary Revascularization
|
||
Recruiting |
NCT05860400 -
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
|
||
Completed |
NCT03540381 -
Relation Among HDL Functionality, Neoatherosclerosis and Target Lesion Revascularization
|
||
Recruiting |
NCT05783804 -
Plaque Reversal With Early, Aggressive Lipid Lowering Therapy
|
||
Completed |
NCT03192579 -
Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial
|
Phase 4 | |
Completed |
NCT03195621 -
Critical Treatment of Coronary Artery Disease
|
N/A | |
Recruiting |
NCT03533959 -
To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy
|
||
Recruiting |
NCT04772768 -
Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease
|
||
Not yet recruiting |
NCT06007248 -
Disease Characteristics of IR-CAD: a Case-control Study
|
||
Recruiting |
NCT03943459 -
Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease
|
Phase 3 | |
Recruiting |
NCT03788369 -
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization
|